يعرض 1 - 10 نتائج من 86 نتيجة بحث عن '"cedres, susana"', وقت الاستعلام: 1.64s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Haakensen , V D , Öjlert , Å K , Thunold , S , Farooqi , S , Nowak , A K , Chin , W L , Grundberg , O , Szejniuk , W M , Cedres , S , Sørensen , J B , Dalen , T S , Lund-Iversen , M , Bjaanæs , M & Helland , Å 2024 , ' UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma – A phase II randomised trial ' , European Journal of Cancer , vol. 202 , 113973 . https://doi.org/10.1016/j.ejca.2024.113973Test

    مصطلحات موضوعية: Immunotherapy, Pleural mesothelioma, Telomerase vaccine

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المساهمون: Institut Mutualiste de Montsouris (IMM), Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Centre Hospitalier Universitaire CHU Grenoble (CHUGA), European Thoracic Oncology Platform, European Organisation for Research and Treatment of Cancer, EORTC

    المصدر: ISSN: 2059-7029 ; ESMO Open ; https://hal.science/hal-04191650Test ; ESMO Open, 2023, 8 (3), ⟨10.1016/j.esmoop.2023.101576⟩.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37285717; hal-04191650; https://hal.science/hal-04191650Test; https://hal.science/hal-04191650/documentTest; https://hal.science/hal-04191650/file/1-s2.0-S2059702923008086-main.pdfTest; PUBMED: 37285717

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Cedres S, Valdivia A, Iranzo P, Callejo A, Pardo N, Navarro A, Martinez-Marti A, Assaf-Pastrana JD Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Felip E Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Thoracic Cancers Translational Genomics Unit, Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cancers;15(24); https://doi.org/10.3390/cancers15245787Test; Cedres S, Valdivia A, Iranzo P, Callejo A, Pardo N, Navarro A, et al. Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy. Cancers. 2023 Dec 10;15(24):5787.; https://hdl.handle.net/11351/10868Test; 001131441100001

  5. 5
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Cedres S, Valdivia A, Assaf-Pastrana JD, Iranzo P, Callejo A, Pardo N, Navarro A, Martinez-Marti A, Priano I, Felip E Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Serna G, Fasani R, Guardia X, Nuciforo P Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Gonzalez-Medina A, Vivancos A Cancer Genomics Lab, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Gonzalo J Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Carbonell C, Frigola J, Amat R Clinical Research Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Navarro V, Dienstmann R Oncology Data Science Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.spreadsheetml.sheet

    العلاقة: Cancers;15(14); https://doi.org/10.3390/cancers15143611Test; Cedres S, Serna G, Gonzalez-Medina A, Valdivia A, Assaf-Pastrana JD, Iranzo P, et al. Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients. Cancers (Basel). 2023 Jul 14;15(14):3611.; https://hdl.handle.net/11351/10139Test; 001035104500001

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Carbonell C, Frigola J, Lenza L, Soleda M, Amat R Thoracic Cancers Translational Genomics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Clinical Research Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Pardo N, Callejo A, Iranzo P, Valdivia A, Cedrés S, Martinez-Marti A, Navarro A Clinical Research Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Priano I Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Gonzalo-Ruiz J Clinical Research Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vivancos A Cancer Genomics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Felip E Thoracic Cancers Translational Genomics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Clinical Research Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Molecular Oncology;17(5); https://doi.org/10.1002/1878-0261.13409Test; Carbonell C, Frigola J, Pardo N, Callejo A, Iranzo P, Valdivia A, et al. Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC. Mol Oncol. 2023 May;17(5):779–91.; https://hdl.handle.net/11351/9835Test; 000957180300001

  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Ponce S, Herrera-Juarez M Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. Cedrés S, Martinez-Marti A, Navarro A, Serres X Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Ricordel C Department of Pulmonology, Centre Hospitalier Universitaire de Rennes, Rennes, France. Isambert N Centre Georges-François Leclerc, Dijon, France. Viteri S Department of Medical Oncology, Instituto Oncológico Rosell, Grupo Quironsalud, Hospital Universitario Dexeus, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Journal for ImmunoTherapy of Cancer;11(9); http://dx.doi.org/10.1136/jitc-2023-007552Test; Ponce S, Cedrés S, Ricordel C, Isambert N, Viteri S, Herrera-Juarez M, et al. ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment. J Immunother Cancer. 2023 Sep;11(9):e007552.; https://hdl.handle.net/11351/10279Test; 001058401700001

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المساهمون: Merck Healthcare KGaA, Fundación Cientifica Asociación Española Contra el Cancer-AECC, the Catalan Government/AGAUR

    المصدر: Journal for ImmunoTherapy of Cancer ; volume 10, issue 4, page e004197 ; ISSN 2051-1426

  10. 10
    دورية أكاديمية